Stocks and InvestingStocks and Investing
Fri, February 18, 2022
Thu, February 17, 2022
Wed, February 16, 2022
Tue, February 15, 2022

Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $20 on, Feb 15th, 2022


Published on 2024-10-27 19:41:03 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $24 to $20 on, Feb 15th, 2022.

Tejas, nor any peers, have made any analyst calls on AKYA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30